Tuesday, August 22, 2017
New Treatment Available for Atopic Dermatitis
Great news for adult patients with moderate to severe atopic dermatitis. There is a new treatment available.. Dupixent!
This is a monoclonal antibody that binds and inhibits interleukin-4 receptor alpha subunit, interfering with interleukin-4
and interleukin-13 cytokines, reducing inflammation and altering immune responsiveness. Directed biologic therapy to the
underlying cause of this severe frustrating disease.
8:30 am edt